Addressing Canada’s Pharmaceutical Research and Development Intensity Gap: The Role of Health Data Transformation.
The life sciences industry, and specifically the pharmaceutical sub-sector, is a major funder of private sector research and development. Canada’s life sciences industry reinvests less of its revenues in research and development (R&D) activities than those in peer countries, which hinders innovation...
| Publicado en: | Healthcare Quarterly Vol. 29; no. 2; pp. 29 - 37 |
|---|---|
| Autores principales: | , |
| Formato: | tables/charts Journal Article |
| Publicado: |
Longwoods Publishing
Jul2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |